Stevanato Group (NYSE:STVN) Director Buys €326,750.00 in Stock

Stevanato Group S.p.A. (NYSE:STVN) Director Donald Morel, Jr. acquired 25,000 shares of the business’s stock in a transaction on Friday, November 6th. The stock was acquired at an average price of €13.07 per share, for a total transaction of €326,750.00. Following the acquisition, the director owned 62,424 shares of the company’s stock, valued at approximately €815,881.68. This trade represents a 66.80% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Stevanato Group Stock Down 2.1%

Shares of NYSE STVN traded down €0.29 on Tuesday, reaching €13.44. 476,532 shares of the company’s stock traded hands, compared to its average volume of 559,780. The business’s 50 day simple moving average is €19.65 and its two-hundred day simple moving average is €17.98. Stevanato Group S.p.A. has a 12 month low of €12.05 and a 12 month high of €25.45. The company has a market cap of $4.07 billion, a price-to-earnings ratio of 23.16, a price-to-earnings-growth ratio of 1.15 and a beta of 0.80. The company has a quick ratio of 1.08, a current ratio of 1.73 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported €0.16 EPS for the quarter, missing analysts’ consensus estimates of €0.17 by (€0.01). The company had revenue of €326.06 million during the quarter. Stevanato Group had a return on equity of 10.51% and a net margin of 11.24%. As a group, equities research analysts forecast that Stevanato Group S.p.A. will post 0.67 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on STVN shares. Citigroup lowered their price target on Stevanato Group from $26.00 to $20.00 and set a “buy” rating for the company in a research report on Wednesday, November 4th. Deutsche Bank Aktiengesellschaft started coverage on shares of Stevanato Group in a research report on Wednesday, October 7th. They set a “hold” rating on the stock. UBS Group reduced their price objective on shares of Stevanato Group from $23.00 to $16.00 and set a “neutral” rating for the company in a research note on Wednesday, November 4th. William Blair cut shares of Stevanato Group from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 4th. Finally, Weiss Ratings raised shares of Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 27th. Two investment analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Stevanato Group currently has an average rating of “Moderate Buy”.

Institutional Trading of Stevanato Group

A number of institutional investors and hedge funds have recently modified their holdings of the business. First Bank & Trust lifted its position in shares of Stevanato Group by 3.4% in the second quarter. First Bank & Trust now owns 18,417 shares of the company’s stock worth $333,000 after buying an additional 603 shares in the last quarter. Fifth Third Bancorp grew its holdings in Stevanato Group by 22.6% during the 1st quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock valued at $58,000 after buying an additional 773 shares in the last quarter. PineStone Asset Management Inc. increased its stake in Stevanato Group by 8.4% in the 3rd quarter. PineStone Asset Management Inc. now owns 41,335 shares of the company’s stock worth $867,000 after acquiring an additional 3,200 shares during the last quarter. Integrated Wealth Concepts LLC bought a new stake in Stevanato Group in the 2nd quarter worth approximately $59,000. Finally, Diversify Wealth Management LLC raised its holdings in shares of Stevanato Group by 23.9% during the 1st quarter. Diversify Wealth Management LLC now owns 18,353 shares of the company’s stock worth $252,000 after acquiring an additional 3,543 shares in the last quarter.

About Stevanato Group

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.